Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
McKinsey
Merck
Colorcon
Harvard Business School

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Solvay Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for SOLVAY, and what generic and branded alternatives to SOLVAY drugs are available?

SOLVAY has sixty-three approved drugs.



Summary for Solvay
US Patents:0
Tradenames:45
Ingredients:34
NDAs:63
Patent Litigation for Solvay: See patent lawsuits for Solvay

Drugs and US Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay MEPROBAMATE meprobamate TABLET;ORAL 084435-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay LITHONATE lithium carbonate CAPSULE;ORAL 016782-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay VERMIDOL piperazine citrate SYRUP;ORAL 080992-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay LITHOTABS lithium carbonate TABLET;ORAL 016980-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay ORASONE prednisone TABLET;ORAL 083009-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay CURRETAB medroxyprogesterone acetate TABLET;ORAL 085686-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay CIN-QUIN quinidine sulfate CAPSULE;ORAL 085297-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 4,085,225   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 4,085,225   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-003 Dec 5, 1994 4,085,225   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-002 Dec 5, 1994 4,085,225   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKesson
Moodys
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.